PROM1 and central nervous system cancer: Accordingly, tyrosine kinase inhibitors AG1478 (Calbiochem®) and gefitinib (Iressa®, ZD1839), suppressed proliferation and induced apoptosis of the CD133+ fractions in three CSC lines established from human gliomas [74].